Back to News
investment

Here's Why I Wouldn't Touch Canopy Growth With a 10‑Foot Pole in 2026

newsfeedback@fool.com (Reuben Gregg Brewer)
Loading...
4 min read
0 likes
⚡ Quantum Brief
The Canadian cannabis producer remains a high-risk investment in 2026, trading as a penny stock near $1.20, signaling financial distress and volatility typical of struggling companies. A recent balance sheet recapitalization pushed out debt maturities but required costly incentives like warrants, highlighting weak financial health and limited access to affordable capital. The company’s all-stock acquisition of MTL Cannabis expands market reach but further dilutes shareholders, complicating profitability amid ongoing losses. Canopy Growth has never achieved profitability, with shrinking losses offering little reassurance for investors seeking sustainable returns in a crowded cannabis sector. Analysts advise most investors to avoid the stock until it proves long-term viability, reserving it only for aggressive traders willing to accept extreme risk.
AI Audio Summary
0:00 / 0:00
Click to play
quantum computing images.jpg
Quantum News · Media Library

Canopy Growth grows marijuana, but it hasn't been the best steward of investor capital.Canopy Growth (CGC +2.56%) is a high-risk investment that should be considered only by the most aggressive investors. That's the big story and, ultimately, why I wouldn't touch it with a 10-foot pole. But if you are considering it, you'll want to think about these key facts before you hit the buy button. Canopy Growth is a penny stock One of the first major warning signs is that the stock is trading around $1. That's penny stock land, an area of the market that is known for being high risk. Stock prices generally only fall that low when a company is struggling. Sure, there could be a huge upside opportunity if a penny stock turns around, but there's material downside risk if the company's business doesn't prove sustainable over the long term. Image source: Getty Images. Notably, penny stocks often struggle to tap the capital markets for cash through stock sales. And when they do, the cost is very high given the low stock price, with investors feeling the hit via increased shareholder dilution. Canopy Growth just recapitalized its balance sheet In addition to the stock price, Canopy Growth's financial strength is a potential issue. In early 2026, the company recapitalized its balance sheet. There were several transactions involved, with the company effectively pushing out its debt maturities. That's a positive; however, to get the deal done, it had to offer incentives, including warrants. This isn't the type of thing a financially strong company usually has to do. ExpandNASDAQ: CGCCanopy GrowthToday's Change(2.56%) $0.03Current Price$1.20Key Data PointsMarket Cap$403MDay's Range$1.17 - $1.2252wk Range$0.77 - $2.38Volume526KAvg Vol28MGross Margin18.25% Canopy Growth is buying another business Despite the low stock price and questions about the company's financial strength, it is still moving ahead with the acquisition of MTL Cannabis. This move is expected to improve the company's geographic positioning in the marijuana sector, but the all-stock deal will increase Canopy Growth's share count. The stock involved here will increase dilution and will make it harder for the company to turn a profit. Canopy Growth is mired in red ink There are clearly several material red flags when you consider Canopy Growth. One of the biggest is the company's ongoing losses. In fact, it has never been profitable. Sure, the losses appear to be getting smaller, but that isn't enough to make this high-risk penny stock worth buying. Most investors should probably watch Canopy Growth from the sidelines. If the business can become sustainably profitable, it may be worth reconsidering it. But until that point, I wouldn't touch it.Read NextFeb 7, 2026 •By Justin PopeIs It Time to Dump Your Shares of Canopy Growth Corp?Feb 2, 2026 •By Prosper Junior Bakiny1 Beaten-Down Stock I Wouldn't Touch With a 10-Foot PoleJan 30, 2026 •By David Jagielski, CPAShould You Buy Canopy Growth Stock Before Feb. 6?Jan 15, 2026 •By Prosper Junior BakinyShould You Buy This Cannabis Stock While It's Under $2?Jan 14, 2026 •By David Jagielski, CPADoes Marijuana Rescheduling in the U.S.

Make Canopy Growth a Good Buy in 2026?Dec 28, 2025 •By Prosper Junior BakinyDo These 2 Cannabis Stocks Have a Future?About the AuthorReuben Gregg Brewer is a contributing Motley Fool stock market analyst covering energy, utilities, REITs, and consumer staples. He is the former director of research at Value Line Publishing, where he rose from mutual fund analyst to equity analyst before leading all research operations. Reuben holds a bachelor’s degree in psychology from SUNY Purchase, a master’s in social work from Columbia University, and an MBA from Regis University. He has been featured as a financial expert on CNBC and in the Financial Times, Barron’s, and InvestmentNews.TMFReubenGBrewerStocks MentionedCanopy GrowthNASDAQ: CGC$1.20 (+2.56%) $+0.03*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

quantum-investment
government-funding

Source Information

Source: The Motley Fool

Discussion

0 professional contributions

Sign in to join this professional discussion.

Be the first to add a constructive contribution.